NACC1 Fusion Hepatic Carcinoma

Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved..

NACC1 fusions. The purpose of this study is to present clinicopathologic and molecular data for a large series of these tumors to better understand their pathogenesis. We identified 11 hepatic tumors with these features. Immunohistochemical and NACC1 and NIPBL fluorescence in situ hybridization assays were performed on all cases. Four cases had available material for whole-genome sequencing (WGS) analysis. Most patients were adult women (mean age: 42 y) who presented with abdominal pain and large hepatic masses (mean size: 14 cm). Ten patients had no known liver disease. Of the patients with follow-up information, 3/9 (33%) pursued aggressive behavior. All tumors were composed of bland cuboidal cells with follicular and solid/trabecular growth patterns in various combinations, were immunoreactive for inhibin, showed albumin mRNA by in situ hybridization, and harbored the NIPBL::NACC1 fusion by fluorescence in situ hybridization. WGS corroborated the presence of the fusion in all 4 tested cases, high tumor mutational burden in 2 cases, and over 30 structural variants per case in 3 sequenced tumors. The cases lacked mutations typical of conventional intrahepatic cholangiocarcinoma. In this report, we describe the largest series of primary inhibin-positive hepatic neoplasms harboring a NIPBL::NACC1 fusion and the first WGS analysis of these tumors. We propose to name this neoplasm NIPBL:NACC1 fusion hepatic carcinoma.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:48

Enthalten in:

The American journal of surgical pathology - 48(2024), 2 vom: 01. Jan., Seite 183-193

Sprache:

Englisch

Beteiligte Personen:

Hissong, Erika [VerfasserIn]
Al Assaad, Majd [VerfasserIn]
Bal, Munita [VerfasserIn]
Reed, Katelyn A [VerfasserIn]
Fornelli, Adele [VerfasserIn]
Levine, Max F [VerfasserIn]
Gundem, Gunes [VerfasserIn]
Semaan, Alissa [VerfasserIn]
Orr, Christine E [VerfasserIn]
Sakhadeo, Uma [VerfasserIn]
Manohar, Jyothi [VerfasserIn]
Sigouros, Michael [VerfasserIn]
Wilkes, David [VerfasserIn]
Sboner, Andrea [VerfasserIn]
Montgomery, Elizabeth A [VerfasserIn]
Graham, Rondell P [VerfasserIn]
Medina-Martínez, Juan S [VerfasserIn]
Robine, Nicolas [VerfasserIn]
Fang, Jiayun M [VerfasserIn]
Choi, Eun-Young K [VerfasserIn]
Westerhoff, Maria [VerfasserIn]
Delgado-de la Mora, Jesús [VerfasserIn]
Caudell, Patricia [VerfasserIn]
Yantiss, Rhonda K [VerfasserIn]
Papaemmanuil, Elli [VerfasserIn]
Elemento, Olivier [VerfasserIn]
Sigel, Carlie [VerfasserIn]
Jessurun, José [VerfasserIn]
Mosquera, Juan Miguel [VerfasserIn]

Links:

Volltext

Themen:

57285-09-3
Biomarkers, Tumor
Cell Cycle Proteins
Inhibins
Journal Article
NACC1 protein, human
NIPBL protein, human
Neoplasm Proteins
Repressor Proteins

Anmerkungen:

Date Completed 24.01.2024

Date Revised 24.01.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1097/PAS.0000000000002159

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM365383600